secwatch.observer — SEC 8-K summary
======================================

Issuer:     Gossamer Bio, Inc. (GOSS)
CIK:        0001728117
Form:       8-K
Filed at:   2026-09-28T20:01:31+00:00
Accession:  0001728117-26-000106
Event type: regulatory
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Gossamer Bio regains Nasdaq minimum bid price compliance after 1-for-80 reverse split
--------------------------------------------------------------------------------

- Gossamer Bio received a Sept. 25, 2026 Nasdaq letter stating it regained compliance with Nasdaq Listing Rule 5450(a)(1) minimum bid price requirement.
- Nasdaq's April 8, 2026 letter had flagged noncompliance because GOSS common stock traded below $1.00 for 30 consecutive business days.
- Gossamer effected a 1-for-80 reverse stock split on Sept. 10, 2026, and GOSS began trading split-adjusted on Nasdaq on Sept. 11, 2026.
- The Nasdaq minimum bid price matter is now closed, according to the Sept. 25, 2026 letter.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1728117/000172811726000106/0001728117-26-000106-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1728117/000172811726000106/goss-20260925.htm
  HTML page:      https://secwatch.observer/filing/0001728117-26-000106

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer